Experimental Anxiety Model for Anxiety Disorders: Relevance to Drug Discovery

Area of Science:

• Neuroscience
• Pharmacology
• Psychiatry

Background:

• Anxiety disorders represent a significant global health burden.
• Developing effective anxiolytic drugs requires robust preclinical and clinical models.
• Existing models may not fully capture the complexity of anxiety and panic.

Purpose of the Study:

• To review and discuss relevant animal and human models for anxiolytic drug development.
• To explore novel tools and techniques for studying anxiety and panic.
• To assess the continued relevance of theoretical frameworks in anxiety research.

Main Methods:

• Review of existing literature on animal models of anxiety.
• Discussion of human models of induced anxiety and panic.
• Inclusion of theoretical models, genetically modified animals (knockout animals), and optogenetic techniques.

Main Results:

• Identified various animal models applicable to anxiolytic drug discovery.
• Highlighted human models involving panic inducers, such as cholecystokinin.
• Emphasized the enduring relevance of the Deakin and Graeff theoretical model.
• Noted the potential of knockout animals and optogenetics as valuable research tools.

Conclusions:

• A comprehensive understanding of diverse models is crucial for advancing anxiolytic drug development.
• Novel techniques like optogenetics offer promising avenues for future research.
• Integrating theoretical insights with experimental models enhances the study of anxiety and panic.